Affymax, Inc. (AFFY)
OTCMKTS · Delayed Price · Currency is USD
0.0008
0.00 (0.00%)
Aug 26, 2025, 2:41 PM EDT
Affymax Market Cap
Affymax has a market cap or net worth of $59.59 thousand as of August 28, 2025. Its market cap has decreased by -88.89% in one year.
Market Cap
59.59K
Enterprise Value
n/a
Revenue
42.00K
Ranking
n/a
PE Ratio
0.01
Stock Price
$0.00
Market Cap Chart
Since December 15, 2006, Affymax's market cap has decreased from 484.83M to 59.59K, a decrease of -99.99%. That is a compound annual growth rate of -38.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2025 | 59.59K | - |
| Dec 31, 2024 | 59.59K | 33.33% |
| Dec 29, 2023 | 44.69K | -85.00% |
| Dec 30, 2022 | 297.96K | -33.33% |
| Dec 31, 2021 | 446.94K | -94.00% |
| Dec 31, 2020 | 7.45M | 300.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 636.43M |
| Elite Pharmaceuticals | 586.30M |
| CytoDyn | 388.66M |
| Northwest Biotherapeutics | 357.21M |
| American Oncology Network | 357.05M |